BPT Crunch

Companies on the Cutting Edge of Healthcare Innovations

back to Marketplace

Triplet Therapeutics

Triplet Therapeutics logo

Clinical Trials


RNA-focused Startups

Triplet Therapeutics, is an early stage start-up biotherapeutics company developing new therapeutic approaches to address triplet repeat disorders such as Huntington’s disease and Myotonic Dystrophy. There are approximately 40 known triple repeat disorders that devastate the lives of people and their families with no known treatment options to date. Triplet aims to change this, developing ground breaking treatments for these patients. The company is led by a highly experienced management team and backed by Atlas Venture.

Posts Mentioning This Company

Top RNA Biotech Startups To Watch in 2021

RNA therapeutics at a glance For many years the focus of therapeutic developments and scientific research was directed at the genome and DNA-related proteins. Yet, there is a completely different level of cell regulation – transcriptome level, presented by RNAs. RNA molecules are not just intermediates between DNA and proteins, …

Top Companies At The Forefront Of RNA Therapeutics Development

Alongside the topic of gene editing technologies that keeps making headlines these days, there is also a wave of breakthroughs in the field of RNA-targeting medicines, primarily falling into the following two categories: antisense oligonucleotides (ASO), and RNA interference (RNAi) technologies. (another promising approach, dealing with editing RNA itself by …